Cangrelor Ticagrelor Transition Study
| Status: | Completed |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/4/2013 |
| Start Date: | January 2013 |
| End Date: | February 2013 |
| Contact: | David J. Schneider, MD |
| Email: | David.Schneider@vtmednet.org |
| Phone: | (802) 847-3734 |
A Study of the Transition From Cangrelor to Ticagrelor, and Ticagrelor to Cangrelor in Patients With Coronary Artery Disease
To demonstrate that patients treated with cangrelor can be directly switched to oral
ticagrelor and that patients treated with ticagrelor can be switched to cangrelor without a
significant decrease in the extent of inhibition of platelet aggregation.
Inclusion Criteria:
- greater than / equal to 18 and less than 75 years of age
1. Previous myocardial infarction defined by admission to the hospital with
elevation of markers of injury or the presence of pathologic q waves on at least
2 contiguous electrocardiogram (ECG) leads.
OR
2. Previous revascularization by PCI or CABG. AND
3. Treatment with ASA 81 mg daily.
Exclusion Criteria:
We found this trial at
1
site
Fletcher Allen Health Care As Vermont’s University Medical Center, we at Fletcher Allen are committed...
Click here to add this to my saved trials
